Renin-Angiotensin system blockade for diabetic nephropathy prevention.
Naviglio
Samuele
S
Pirozzi
Fabrizio
F
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage; D001713:Biphenyl Compounds; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D004656:Enalapril / Q000008:administration & dosage; D005260:Female; D006801:Humans; D019808:Losartan / Q000008:administration & dosage; D008297:Male; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects*; D018570:Risk Assessment; D013777:Tetrazoles / Q000008:administration & dosage; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D004656:Enalapril; D019808:Losartan; C081643:candesartan